Nova Mentis Life Science (TSE:NOVA) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nova Mentis Life Science Corp. appoints Steve Loutskou as the new President and CEO, aiming to drive future growth with his extensive entrepreneurial experience. This leadership change follows the resignation of William Rascan, who significantly contributed to the company’s development, including securing an orphan drug designation for psilocybin treatment.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.